MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, LGNXZ made $268,087K in revenue. $124,453K in net income. Net profit margin of 46.42%.

Income Overview

Revenue
$268,087K
Net Income
$124,453K
Net Profit Margin
46.42%
EPS
$6.13
Unit: Thousand (K) dollars
Revenue Breakdown
    • Intangible Royalty Assets
    • Income From Divestiture Transact...
    • Material Sales Captisol
    • Others
Revenue Breakdown
    • Income From Divestiture Transact...
    • Material Sales Captisol Core
    • Royalty Kyprolis
    • Others

Income Statement
2025-12-31
Total revenue and income
268,087
Cost of captisol
14,549
Amortization of intangibles
32,708
Research and development
81,182
General and administrative
92,449
Financial royalty assets impairment
6,197
Fair value adjustments to partner program derivatives
0
Total operating costs and expenses
227,085
Gain on sale of pelican
0
Operating income (loss) from continuing operations
41,002
Gain from short-term investments
18,433
Gain (loss) from change in fair value of equity method investments and other investments
90,670
Interest income
13,659
Interest expense
4,715
Other non-operating expense, net
-89
Total non-operating income, net
117,958
Income before income tax from continuing operations
158,960
Income tax expense
34,507
Net income (loss) from continuing operations
124,453
Net income (loss)
124,453
Basic EPS
6.44
Diluted EPS
6.13
Basic Average Shares
19,338,000
Diluted Average Shares
20,294,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Intangible Royalty Assets$132,534K Financial Royalty Assets$28,467K Income FromDivestiture Transactions$53,072K License Fees$6,988K Service$6,813K Royalty$161,001K Contract Revenue AndIncome$66,873K Material Sales Captisol$40,213K Gain (loss) fromchange in fair value of...$90,670K Gain from short-terminvestments$18,433K Interest income$13,659K Total revenue andincome$268,087K Total non-operatingincome, net$117,958K Operating income (loss)from continuing...$41,002K Interest expense$4,715K Other non-operatingexpense, net-$89K Total operating costsand expenses$227,085K Income before incometax from continuing...$158,960K General andadministrative$92,449K Research and development$81,182K Amortization of intangibles$32,708K Cost of captisol$14,549K Financial royalty assetsimpairment$6,197K Net income (loss)from continuing...$124,453K Income tax expense$34,507K Net income (loss)$124,453K

LIGAND PHARMACEUTICALS INC (LGNXZ)

LIGAND PHARMACEUTICALS INC (LGNXZ)